Epigenetically acting drugs could support cancer immunotherapy

By Science X staff

Epigenetically active drugs enable the cell to read parts oft he genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as scientists from the German Cancer Research Center and the Univers

You are viewing a robot-friendly page.Click hereto reload in standard format.